HIV Associated Preeclampsia: A Multifactorial Appraisal

HIV Associated Preeclampsia: A Multifactorial Appraisal

<i>Introduction:</i> This review explores angiogenesis, vascular dysfunction, the complement system, RAAS, apoptosis and NETosis as potential pathways that are dysregulated during preeclampsia, HIV infection and ART usage. <i>Results:</i> HIV-1 accessory and matrix proteins a...

Full description

Bibliographic Details
Main Authors:	Thajasvarie Naicker, Nalini Govender, Tashlen Abel, Nitalia Naidoo, Merantha Moodley, Yazira Pillay, Shoohana Singh, Olive Pearl Khaliq, Jagidesa Moodley
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	International Journal of Molecular Sciences
Subjects:	HIV antiretroviral therapy preeclampsia complement system angiogenesis RAAS
Online Access:	https://www.mdpi.com/1422-0067/22/17/9157

Similar Items

Vascular Endothelial Growth Factor Receptor 2: Molecular Mechanism and Therapeutic Potential in Preeclampsia Comorbidity with Human Immunodeficiency Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Infections
by: Tashlen Abel, et al.
Published: (2022-11-01)

Is the central complement component C3 altered in the synergy of HIV infection and preeclampsia?
by: Mikyle David, et al.
Published: (2023-12-01)

THE ROLE OF HUMAN COMPLEMENT PROTEIN FACTOR B AND FACTORP/PROPERDIN IN HIV-ASSOCIATED PRE-ECLAMPSIA
by: Phumelele Kikine, et al.
Published: (2022-01-01)

South African medicinal plants displaying angiotensin-converting enzyme inhibition: Potential use in the management of preeclampsia
by: Rebecca Reddy, et al.
Published: (2022-04-01)

Dysregulation of circulating sTie2 and sHER2 in HIV-infected women with preeclampsia
by: Mduduzi Mazibuko, et al.
Published: (2019-04-01)

Role of angiopoietin-2, endoglin, and placental growth factor in HIV-associated preeclampsia
by: Nokuzola Mbhele, et al.
Published: (2017-07-01)

Serum levels of platelet endothelial cell adhesion molecule-1 (PECAM-1) and soluble vascular endothelial growth factor receptor (sVEGFR)-1 and -2 in HIV associated preeclampsia
by: Semone Thakoordeen, et al.
Published: (2017-04-01)

The complement system in preeclampsia: a review of its activation and endothelial injury in the triad of COVID-19 infection and HIV-associated preeclampsia
by: Mikyle David, et al.
Published: (2023-07-01)

Urinary clusterin and glutathione-s-transferase levels in HIV positive normotensive and preeclamptic pregnancies
by: Frederick Odun-Ayo, et al.
Published: (2018-07-01)

Differential expression of miRNAs are associated with the insulin signaling pathway in preeclampsia and gestational hypertension
by: Olive P Khaliq, et al.
Published: (2018-11-01)

Placenta-derived exosomes: potential biomarkers of preeclampsia
by: Pillay P, et al.
Published: (2017-10-01)

Expression of plasma nuclear factor-kappa B cells (NF-κB) and Inhibitory subunit kappa B alpha (IκB-α) in HIV-associated pre-eclampsia
by: Bambanani Zozo, et al.
Published: (2021-01-01)

Molecular Advances in Preeclampsia and HELLP Syndrome
by: Angeliki Gardikioti, et al.
Published: (2022-03-01)

COVID-19 vaccine hesitancy among pregnant women in an antenatal clinic in Durban, South Africa
by: Sahra Ashkir, et al.
Published: (2023-08-01)

Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia
by: Ai-ris Yonekura Collier, et al.
Published: (2019-07-01)

Polymorphisms within vitamin D binding protein gene within a Preeclamptic South African population
by: Yeshnee Naidoo, et al.
Published: (2019-10-01)

Prevalence of Vitamin D deficiency in a multiracial female population in KwaZulu-Natal province, South Africa
by: Yeshnee Naidoo, et al.
Published: (2019-07-01)

Second victims of obstetric care – Support for healthcare professionals in KwaZulu-Natal, South Africa
by: Puvashnee Nydoo, et al.
Published: (2022-02-01)

Depressive scores in newly diagnosed HIV-infected and HIV-uninfected pregnant women
by: Puvashnee Nydoo, et al.
Published: (2017-12-01)

The Immunogenetic Conundrum of Preeclampsia
by: A. Inkeri Lokki, et al.
Published: (2018-11-01)

The Placental Innate Immune System Is Altered in Early-Onset Preeclampsia, but Not in Late-Onset Preeclampsia
by: Michelle Broekhuizen, et al.
Published: (2021-12-01)

Dysregulation of Complement Activation and Placental Dysfunction: A Potential Target to Treat Preeclampsia?
by: E. Pierik, et al.
Published: (2020-01-01)

Adipsin of the Alternative Complement Pathway Is a Potential Predictor for Preeclampsia in Early Pregnancy
by: Min Liu, et al.
Published: (2021-10-01)

Effect of vascular endothelial growth factors A, C, and D in HIV-associated pre-eclampsia
by: Gugulethu Promise Shange, et al.
Published: (2017-04-01)

Role of kidney biomarkers [Kidney injury molecule-1, Calbindin, Interleukin-18 and Monocyte chemoattractant protein-1] in HIV associated pre-eclampsia
by: Soumaya Abdullatif Eltounali, et al.
Published: (2017-10-01)

Neuropathological complications associated with hypertensive disorders of pregnancy
by: Adedayo Damilare Adekomi, et al.
Published: (2019-07-01)

A clinical audit of maternal syphilis in a regional hospital in KwaZulu-Natal, South Africa
by: Onankoy A. Onyangunga, et al.
Published: (2020-04-01)

Protective role of complement factor H against the development of preeclampsia
by: Hadida Yasmin, et al.
Published: (2024-02-01)

Association between preeclampsia and HIV: a case-control study in urban South AfricaAJOG Global Reports at a Glance
by: Mpho Lerato Sikhosana, MBBCh, MPH, FCPath (SA)Viro, et al.
Published: (2022-08-01)

Pre-eclampsia with severe features: management of antihypertensive therapy in the postpartum period
by: Nnabuike Chibuoke Ngene, et al.
Published: (2020-07-01)

Morphometric image analysis of placental C-type lectin domain family 2, member D (CLEC2D) immuno-expression in HIV associated pre-eclampsia
by: Deneshree Varaden, et al.
Published: (2019-07-01)

Analysis of Complement C3 Gene Reveals Susceptibility to Severe Preeclampsia
by: A. Inkeri Lokki, et al.
Published: (2017-05-01)

Circulating Levels of Anti-C1q and Anti-Factor H Autoantibodies and Their Targets in Normal Pregnancy and Preeclampsia
by: Douwe Jan Dijkstra, et al.
Published: (2022-03-01)

Obstetric-associated lower urinary tract injuries: A case series from a tertiary centre in a low-resource setting
by: Shantel Naicker, et al.
Published: (2020-07-01)

The placental vascular endothelial growth factor polymorphisms and preeclampsia/preeclampsia severity
by: Farshid Keshavarzi, et al.
Published: (2017-10-01)

Asociación entre hiperhomocisteinemia y preeclampsia Association between hyperhomocysteinemia and preeclampsia
by: Jorge Mario Gómez Jiménez, et al.
Published: (2002-03-01)

Complement in Reproductive White Adipose Tissue Characterizes the Obese Preeclamptic-Like BPH/5 Mouse Prior to and During Pregnancy
by: Kelsey N. Olson, et al.
Published: (2020-09-01)

Neopterin, PMN Elastase, and Complement Components as Monitoring Parameters in Women with the Syndrome of Hemolysis, Elevated Liver Enzymes and Low Platelet Count
by: Haeger Magnus, et al.
Published: (1993-08-01)

Maternal serum perlecan levels in women with preeclampsia
by: Murat Akbas, et al.
Published: (2020-01-01)

Can Betatrophin Predict the Risk of Preeclampsia?
by: Engin Ersin Simsek, et al.
Published: (2018-10-01)